STROPHANTIN-DARNITSA

The drug has cardiotonic action, increases the force and velocity of myocardial contractions (positive inotropic effect), reduces heart rate (negative chronotropic effect), reduces atrioventricular conduction (negative dromotropic effect).

learn more

STROPHANTIN-DARNITSA

The drug has cardiotonic action

The drug has cardiotonic action, increases the force and velocity of myocardial contractions (positive inotropic effect), reduces heart rate (negative chronotropic effect), reduces atrioventricular conduction (negative dromotropic effect).

In heart failure it increases cardiac stroke volume and minute volume, improves ventricular emptying, leading to improvement in blood flow.

It is used in acute heart failure, chronic heart failure stage IIb-III (III-IV stage according to NYHA classification), supraventricular tachycardia, atrial fibrillation.

More in instructions (Ukrainian version)
INN
Strophanthinum
Package
0.25 mg/ml,10 x 1 ml
Form of release
Solution for injection
АТС class
C01A C01

See also

Specialized publications intended for medical institutions and doctors Limitations in obtaining information